Effect of heparin and low molecular weight heparins on platelets
Vermylen, J.G.
Seminars in Thrombosis and Hemostasis 19(Suppl 1): 20-21
1993
ISSN/ISBN: 0094-6176 PMID: 8395723 Document Number: 409880
Document emailed within 1 workday
Related Documents
Ghali, W.A.; Pannatier, A.; Tsuyuki, R.T.; Hull, R.D.; MacKay, E.; Quan, H.; Cornuz, J. 2002: Transition from unfractionated heparin to low molecular weight heparins Thrombosis and Haemostasis 88(3): 539-540Morita, Y.; Makino, H.; Ota, K.; Wada, J.; Shikata, K.; Kashihara, N.; Ikeda, S.; Ogura, T.; Ota, Z. 1994: Effect of heparin and low-molecular-weight heparin on proliferative glomerulonephritis Nihon Jinzo Gakkai Shi 36(7): 832-838
Ebell, M.H. 1994: Low molecular weight heparins for DVT Journal of Family Practice 39(5): 501-502
Agnelli, G.; Cosmi, B. 1990: Low molecular weight heparins Medicina 10(1): 9-15
Drouet, L. 1993: Low molecular weight heparins Presse Medicale 22(40): 2002-2008
Fareed, J.; Hoppensteadt, D.; Jeske, W.; Clarizio, R.; Walenga, J.M. 1998: Low molecular weight heparins: are they different? Canadian Journal of Cardiology 14 Suppl E: 28e-34e
Doutremepuich, C.; Puyal, C.; Lalanne, M.C.; Doutremepuich, F.; De Sèze, O. 1990: How to standardize low molecular weight heparins Annales de Biologie Clinique 48(4): 221-225
Samama, M.M.; Michaut-Paterno, F. 1991: Therapeutic indications of low molecular weight heparins Archives des Maladies du Coeur et des Vaisseaux 84(11 Suppl): 1733-1743
Mammen, E.F.; Arcelus, J.; Messmore, H.; Altman, R.; Nurmohamed, M.; Eldor, A. 1999: Clinical differentiation of low molecular weight heparins Seminars in Thrombosis and Hemostasis 25(Suppl 3): 135-144
Horellou, M.H.; Samama, M. 1991: Low molecular weight heparins in everyday practice Journal des Maladies Vasculaires 16(2): 179-183
Hunt, D. 1998: Low-molecular-weight heparins in clinical practice Southern Medical Journal 91(1): 2-10
Vignes, S.; Meyer, G.; Marjanovic, Z.; Farge-Bancel, D. 1997: Current indications of low-molecular-weight heparins Annales de Medecine Interne 148(2): 154-162
De Lorenzo, F.; Dotsenko, O.; Kakkar, V.V. 2005: Low molecular weight heparins in cardiovascular medicine Minerva Cardioangiologica 53(6): 585-603
Psuja, P. 1988: Effect of antithrombin IIi on the binding of heparin and its low molecular weight fraction CY 216 with endothelium in vitro Acta Haematologica Polonica 19(3-4): 143-149
Brunkwall, J.; Mätzsch, T.; Bergqvist, D. 1990: The effect of unfractionated and low-molecular-weight heparin on the release of prostacyclin from the arterial wall Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 1(6): 641-645
Barrowcliffe, T.W.; Le Shirley, Y. 1989: The effect of calcium chloride on anti-Xa activity of heparin and its molecular weight fractions Thrombosis and Haemostasis 62(3): 950-954
Bergqvist, D. 1992: Review of clinical trials of low molecular weight heparins European Journal of Surgery 158(2): 67-78
Linhardt, R.J.; Gunay, N.S. 1999: Production and chemical processing of low molecular weight heparins Seminars in Thrombosis and Hemostasis 25(Suppl 3): 5-16
Ramasamy, I.; Kennedy, J.; Tan, K. 2003: Capillary electrophoresis for characterization of low molecular weight heparins Laboratory Hematology: Official Publication of the International Society for Laboratory Hematology 9(2): 64-66
Bóveda Treviño, J.L.; Gràcia Gozalo, R.M.; Barrabés, J.; Monasterio, J. 1991: Thromboembolic disease and thrombocytopenia associated with the use of low-molecular weight heparins Medicina Clinica 96(18): 718-719